Introduction
COPD is characterized by persistent airflow limitation, which usually progresses and is associated with an increased chronic inflammatory response. 1, 2 The severity of the disease in individual patients is influenced by exacerbations, hospitalizations, and coexisting diseases. 3 Poor airflow is connected with the presence of emphysema and inflammation progressing in bronchioles.
The criteria applied to define socioeconomic differences include education, income, and occupation. 12, 13 The influence of sociodemographic factors was rarely assessed in the previous studies regarding QOL in patients with COPD. The influence of socioeconomic factors on QOL has been demonstrated in worldwide studies in patients with bronchial asthma, 14 cerebral stroke, 15 prostate cancer, 16 and chronic renal failure. 17 Only a few publications assess the impact of socioeconomic factors on QOL in COPD, and they present various reports. Some authors confirm, while others completely deny, their influence on QOL. 18, 19 In our opinion, taking into consideration such a significant issue may contribute to the understanding of some determinants of the burden of the disease and its impact in the life of patients with COPD. Therefore, the objective of this study was to determine the impact of selected sociodemographic and clinical factors on QOL and level of illness acceptance (LIA) of patients with COPD.
Patients and methods

Patient characteristics
The study involved a group of 100 adult patients (34 women and 66 men) aged from 39 to 84 years (mean age: 60.9 years) who were recruited under inpatient conditions. All COPD patients were treated for at least 6 months in the Allergology Clinic at the Department of Internal Medicine, Geriatrics, and Allergology, Wroclaw Medical University, Poland.
Up to five comorbidities were observed among the participants of the study. The prevalence of comorbidities for hypertension was 27% and that for diabetes was 23%. The participants also suffered from atherosclerosis (12%); circulatory failure (8%); asthma (7%); myocardial infarction (5%); rheumatoid arthritis and prostatic hypertrophy (4%); heart failure, cholelithiasis, and glaucoma (3%); chronic coronary heart disease, kidney failure, and cerebral stroke (2%); as well as other coexisting diseases (7%). The clinical characteristics of the studied patients including spirometry, duration of disease, GOLD classification, and other important COPD-related variables are summarized in Table 1 .
The largest group was 61-70 years old (38%) and 51-60 years old (30%). Fourteen percent of the respondents aged from 41 to 50 years, while the number of respondents aged from 40 to .70 years was the same at 9%. When analyzing the place of residence, it was found that the majority of patients (46%) live in the cities with over 50,000 people. Of the inhabitants, 39% of the respondents live in the cities with up to 50,000 people. The remaining 15% live in the countryside. In the group of women, 62% of the respondents were married, while 38% of the respondents were single, while in the male group 52% were married and 48% were single.
ethical consideration
The study was approved by the Bioethics Committee of Wroclaw Medical University, Poland (approval no KB-481/2015). All participants gave written informed consent prior to study participation. The study was conducted in accordance with the guidelines of the Declaration of Helsinki and the principles of Good Clinical Practice as well as in respect for the rights and dignity of the other person. The research project was not funded by national grants or other external sources.
Qualification criteria
The inclusion criteria in the study are as follows: 1) age $18 years, 2) diagnosed with COPD based on medical examinations, and 3) the written informed consent of each patient to participate in the study. The exclusion criteria were 1) no consent to participate in the study, 2) mental disorders or mental illness, and 3) other conditions that make patients unable to fill in surveys. Each patient underwent 1) full history of clinical examination, 2) chest X-ray (anteroposterior and lateral), 3) pulmonary function tests (spirometry), and 4) laboratory tests with blood gas analysis. Additionally, we used flow-volume loops by spirometry as a different test for asthma or COPD, to show whether airflow is appropriate for a particular lung volume. Moreover, the lack of coexistence of mental illness or disorder as exclusion criterion was obtained based on psychiatric consultation.
study outcomes
The study attempted to show the correlation between the level of QOL and LIA with selected sociodemographic factors. For this purpose, 15 research problems were identified, with the same number of hypotheses being analyzed. All these items 
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Quality of life in COPD were specified and described in the "Results" section due to their expanded character.
Measurement tools
First, a detailed analysis of medical data in terms of the present and past clinical conditions of each COPD patient was performed. The main measurement tools for scientific purposes were questionnaire methods. From all of the studied patients, the recent sociodemographic data on gender, age, marital status, education, and livelihoods were collected. All respondents received questionnaires along with written information about the study, which was voluntary and provided full anonymity. The respondents completed questionnaires with the assistance of the investigator. The following research tools were used:
Short Form-36 health survey (SF-36) SF-36 is a well-known tool for overall health-related QOL, consisting of 36 questions that make up eight dimensions relating to mental and physical health. The individual questionnaire questions concern 1) physical functioning, 2) role limitations due to physical problems, 3) bodily pain, 4) general health perception, 5) vitality, 6) social functioning (SF), 7) mental health (MH), and (8) role limitation due to emotional problems. In the next stage, the hypothesis was verified that the cutoff value, above which significant QOL deterioration and LIA decrease, is 60 years (Table 3) .
20,21
Problem 3: is the QOl level dependent on education?
hypothesis: patients with higher education are characterized by higher QOL than patients with primary, secondary, and vocational education In the next stage, the hypothesis was verified that people with higher education had higher QOL and LIA than patients with primary, secondary, and vocational education (Table 4) . In the next stage, the hypothesis was verified that people living in cities had higher QOL and LIA than those living in the countryside (Table 5 ).
Problem 5: is the QOL and LIA levels dependent on the incidence of dyspnea?
hypothesis: higher incidence of dyspnea decreases QOl and lIa in patients with COPD
In the study group, there were four patients who never had dyspnea, 41 with dyspnea after only high physical activity, 33 with dyspnea after moderate exercise, 19 with dyspnea even after a slight activity, and three patients complaining of dyspnea at rest. Analysis of Spearman (rho) correlation coefficients showed that, with an increase in the incidence of dyspnea, there is a statistically significant increase in physical (rho =0.582; P,0.001) and mental dimensions (R=0.442; 
051).
In the next stage, the hypothesis was verified that the cutoff value above which significant QOL deterioration and LIA decrease is the duration of COPD over 5 years (Table 6 ).
Problem 7: is the QOl and lIa levels dependent on financial income? Hypothesis: patients who are affluent show higher QOl and better lIa
In the study group, there were three patients with average income per family member not exceeding 500 PLN per month (about €120), 25 persons with an average income of 500-1,000 PLN (about €120-240), 34 persons with an average income of 1,000-1,500 PLN (about €240-360), Table 4 Comparison of the statistical characteristics of particular dimensions of the general and specific QOL and LIA in the subgroups of patients with higher education and other higher 
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Quality of life in COPD Problem 8: is there a relationship between QOL and smoking?
Hypothesis: patients currently smoking cigarettes are characterized by more frequent dyspnea and lower QOL than non-smokers
In the study group, there were 49 active smokers and 51 non-smokers. Statistical analysis did not show that active smokers were significantly different from non-smokers in terms of either QOL or LIA scores (Table 7 ).
Problem 9: does the body mass index (BMI) affect QOL level?
hypothesis: obese or overweight or underweight patients exhibit lower QOl than patients with normal BMI
In the study group, there were 40 patients with normal body weight, 50 patients with overweight, and 10 with obesity. Analysis of Spearman (rho) correlation coefficients did not show a statistically significant increase of BMI in physical (rho =0.052; P=0.607) and mental dimensions (rho =−0.118; P=0.241) of SF-36, as well as the subscales "Activity" (rho =−0.002; P=0.983) and "Impact" (rho =−0.029; P=0.777), and global SGRQ score (rho =−0.043; P=0.672), as well as in AIS value (rho =0.005; P=0.958).
In the next stage, the hypothesis was verified that people with abnormal relative weight (overweight or obesity) had worse QOL and lower LIA than patients with normal body weight ( Table 8 ). In the study group, 78 people declared that they received support from their relatives and 22 patients said they did not receive such support (Table 9 ). In the next stage, it was verified that support received from relatives was able to neutralize the adverse effects of a longer period of COPD on patients' QOL and LIA. Analysis of interactions of effects by sigma-constraint parameterization showed that support from relatives did not adversely affect longer (over 5 years) duration of COPD on physical (β=0.067; P=0.560) and mental dimensions (β=0.028; P=0,814) of SF-36, as well as the subscales "Symptoms" (β=−0.132; P=0.298), "Activity" (β=-0,132; P=0.298), and the global SGRQ score (β=0.092; P=0.430), as well as in AIS value (β=−0.144; P=0.240).
Problem 11: is there a relationship between the occurrence of comorbidities and QOl and lIa?
hypothesis: patients with comorbidities have lower QOl and worse disease tolerance than non-comorbid patients
In the study group, 56 people presented comorbidities, and 44 patients were free of comorbidities. Patients with comorbidities have shown significantly higher results for physical and mental dimensions of SF-36, as well as the subscales "Symptoms," "Activity," and "Impact," and In the study group, 48 patients were with a positive family history of respiratory diseases and 52 patients were with no family history of such diseases. It has been shown that patients with a positive family history of respiratory illness have significantly higher physical dimension of SF-36, as well as the subscales "Symptoms," "Activity," and "Impact,"
and SGRQ global scores, as well as significantly lower AIS values than patients whose closest relatives did not have respiratory diseases. There were no significant differences in mental dimension of SF-36 (Table 11 ).
Problem 13: is QOl dependence associated with the use of oxygen therapy?
hypothesis: patients using oxygen therapy show higher QOl than patients who do not use it
In the study group, 19 patients were undertaking oxygen therapy and 81 patients did not require oxygen therapy. It has been shown that patients receiving oxygen therapy presented significantly higher physical and mental dimensions of SF-36, as well as the subscales "Symptoms," "Activity," "Impact," and global SGRQ scores, as well as significantly lower AIS values than those who did not require oxygen therapy (Table 12 ).
Problem 14: does anxiety in COPD women have a greater effect on lowering of QOl than men's anxiety?
Hypothesis: female patients are more likely to have anxiety than men of the same age
In the study group, 23 patients declared that they had no anxiety disorder, and for 22, 33, and 22 patients, anxiety was a small, medium, and large problem, respectively. Spearman's correlation coefficient (rho) analysis showed that, with increased anxiety, there is a statistically significant increase in physical (rho =0.640; P,0.001) and mental dimensions (rho =0.601, P,0.001) of SF-36, as well as the subscales "Symptoms" (rho =0.567; P,0.001), "Activity" (rho =0.567; P,0.001), and "Impact" (rho =0.665; P,0.001) and the global SGRQ score (rho =0.687; P,0.001), as well as a significant decrease in AIS values (rho =−0.630; P,0.001).
In the next stage of the analysis, whether the sex and age of the patients increased the adverse effects of anxiety on QOL and LIA was verified. Analysis of the effects of the sigma-constraint-based interaction showed that the sex of the respondents and their age did not aggravate the adverse effects of anxiety on physical dimension (β=0. 
Discussion
Today, increasing attention is paid to QOL in chronic diseases of the respiratory system. Health-related QOL studies confirm that people with COPD require holistic approach by health care workers who should take into account not only the medical parameters but also other indicators that influence the overall well-being, that is, mental status or socioeconomic status. Thus, it is necessary to carry out studies detecting potential determinants affecting the assessment of QOL in COPD patients, and identifying these factors will be helpful in planning comprehensive care plan for this group of patients.
The results of our study show that along with age there is a significant reduction of both QOL and LIA in COPD patients. These changes are particularly evident in patients over 60 years. Similar results were obtained by Grochans et al 26 in studies on the Polish population, which found that elderly 
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Quality of life in COPD people had a lower QOL than younger patients. Our results in this aspect also confirm the results obtained in Polish 27 and Spanish 28 studies. Epidemiological worldwide studies on COPD show that the disease mostly affects men. 29, 30 This is also confirmed by the results of Polish studies by Majda and Józefowska 31 -in their own material, 66% of participants were male. It has to be noted that studies by Grochans et al 32 and Kupcewicz and Abramowicz 27 did not show sex-related effects on QOL in patients with COPD, and our study did not confirm any correlation either. However, some researchers 33, 34 point to lower QOL levels in women with COPD.
COPD is a chronic disease that lowers QOL and causes problems with LIA, and about 20% of patients are not reconciled to the disease. A similar indicator of disease acceptance is presented by Majda and Józefowska. 31 In our study, the disease acceptance was 22.8 points for men and 21.7 points for women. Higher LIA scores were obtained by Olek et al, 35 where disease acceptance score was 24 points in women and 22.5 points in men. Our analysis did not show any significant difference between men and women in terms of either QOL or LIA.
A study by Jankowska-Polańska et al 36 showed that LIA was significantly negatively affected by older age, lower education, longer duration of illness, number of hospitalizations, stage of illness, dyspnea, limitations in daily activities, pharmacological treatment, level of knowledge, and applied health behaviors.
Our analysis did not show any significant difference between urban and rural residents in terms of any of the analyzed QOL or LIA domains, except for MH scores obtained in an SF-36 questionnaire which were significantly higher for rural patients. This means that living in rural areas do not adversely affect neither QOL nor LIA in COPD patients. Kupcewicz and Abramowicz 27 obtained opposite results. Another factor considered in the study was an exacerbation of dyspnea and its negative effect on QOL and LIA which was found in our study. A similar connection in COPD patients was demonstrated by Jankowska-Polańska et al 36 and Kupcewicz and Abramowicz 27 as well as Kołcz and Rożek-Mróz 37 in relation to the rehabilitation effect. Our study confirmed that longer disease duration affects QOL in COPD patients and that it also significantly reduces LIA. Moreover, these unfavorable changes persist even after 5 years after COPD diagnosis. Kupcewicz and Abramowicz 27 also found that disease duration of .10 years had a lower QOL score.
This study logically confirms that decrease in the average monthly income per family member was transferred into a difficult financial situation of COPD patients and is directly reflected in lower QOL and LIA. Many authors point out lower socioeconomic status as a significant factor impeding better QOL levels. 38, 39 A similar relationship was found by Kieczka 40 and Głębocka and Szarzyńska. 41 Many studies show that the vast of COPD patients are smokers or ex-smokers. 26, 42 In our study, active smoking did not result in a significant deterioration of QOL or LIA or higher incidence of dyspnea. It should also be mentioned that in our study we observed a surprisingly high group of nonsmoking patients which may indicate an effective secondary prevention and successful education in our COPD patients. Also, Tillmann and Silcock, 43 in turn, after a comparative analysis of smokers and non-smokers, found no difference in the QOL assessment. Grochans et al 26 obtained opposite results and associated smoking with lower QOL in COPD patients. Prigatano et al 44 showed that QOL in smokers is lower than that in ex-smokers.
The most important factor in COPD is the nutritional status of the patient. Our findings did not show that individuals with abnormal BMI differed significantly from patients with normal body weight in terms of any of the analyzed QOL or LIA domains. Kupcewicz and Abramowicz 27 found that nine patients with obesity obtained lower QOL scores than patients with normal body weight.
In the present study, the support of the closest people resulted in the improvement of QOL in patients with COPD and the increase of LIA. However, even this kind of support is not able to neutralize the adverse effect of long-term illness on QOL and LIA for associated conditions. Kurowska and Brojakowska 45 emphasized the level of social support for COPD patients and observed that QOL in this group of patients differs significantly depending on the support received from the family.
The next stage of the study was the analysis of comorbidities and their impact on QOL and LIA. It should be emphasized that the prevalence of two significant comorbidities in our study was 23% for diabetes and only 2% for chronic coronary heart disease, kidney failure, and cerebral stroke, and it may be expected that these patients may be treated as a potentially high-risk group for cardiovascular events in the future perspective and that the preliminary prevention procedures should be implemented immediately. Brodnicka et al 46 found comorbidities in 95% of patients, and Kupcewicz and Abramowicz 27 reported comorbidities in about 40% (56% in our study). Most common comorbidities were diabetes (46%), hypertension (46%), and heart failure (11%). The study by Antonelli Incalzi et al 47 conducted in a group of 270 patients with COPD enumerated hypertension (28%), diabetes (14%), and coronary heart disease (10%).
Our study also found that a positive family history of respiratory disorders translates into lower QOL (especially in the physical domain) and lower LIA in COPD patients. However, a positive family history is not objectively reflected in the higher frequency of hospital admissions due to exacerbation of COPD.
It was observed that a long-term oxygen therapy in COPD patients is responsible for the significant reduction in QOL. Our study confirms this rule because patients presented significantly lower scores for QOL and AIS than patients who did not receive oxygen therapy. Studies by Andersson et al 48 showed that QOL in hospitalized patients who undertook long-term oxygen therapy increased after 3 and 12 months of treatment in their functional and mental status. Eaton et al 49 suggest that even a short-term 12-week oxygen therapy is associated with improvement in QOL; however, 41% of patients refuse to continue home oxygen therapy.
We found that increased anxiety translates into a significant worsening of QOL and lowers LIA in COPD patients. These adverse effects of anxiety are observed regardless of sex and age of the patients. According to a literature review, patients with COPD require psychological support, especially in advanced stages, as they experience a significant change in self-esteem and emotional functioning and SF. The prevalence of anxiety and depression is estimated at 25%. 50 Only two studies assess LIA in COPD patients, namely, Jankowska-Polańska et al 36 and Olek et al, 35 that provide confirmation for the present study results. The abovementioned analyses on LIA were influenced by age, education, duration of illness, and severity of dyspnea. These correlations were confirmed in our study. The study results lead to a conclusion that the assessment of QOL in COPD patients allows to define and confirm further determinants affecting the QOL of patients in this group. It helps to deliver an adequate care adapted to the needs of patients with the improvement of QOL as a priority.
study limitations
There are few limitations in this study which need to be considered. First, we are aware that comorbidities may be an important confounder for the relationships under study. Therefore, in the future studies, the number as well as the severity of such comorbidities that may interfere with the analyzed relationships concerning or duration of the disease should be taken into consideration. Another potential limitation is the lack of analysis based on the relation to the severity of the disease, limitation of exercise capacity, frequency of exacerbations, and QOL scales. We should also present the severity of COPD or even assign the patients into comparative groups regarding this indicator, which could be a confounding factor for correlations of QOL with age and duration of the disease. An adequate scales such as Medical Research Council for the assessment of COPD-related dyspnea and COPD Assessment Test or evaluation of COPD impact on health status should be also included.
Conclusion
The present findings showed that Polish patients with COPD had reduced levels of both QOL and LIA. Such determinants as exacerbation of dyspnea, longer duration of illness, comorbidities, use of oxygen therapy, and positive family history of respiratory disease affected QOL negatively. Assessment and identification of selected sociodemographic and clinical factors in COPD patients are likely to improve QOL and LIA and optimize management, leading to better patient outcomes.
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